These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8480358)

  • 1. Selection of white cell-reduced blood components for transfusions during early infancy.
    Strauss RG
    Transfusion; 1993 Apr; 33(4):352-7. PubMed ID: 8480358
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of alloimmunization in patients with acute leukemia by use of white cell-reduced blood components--a randomized trial.
    Oksanen K; Kekomäki R; Ruutu T; Koskimies S; Myllylä G
    Transfusion; 1991 Sep; 31(7):588-94. PubMed ID: 1891788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of white cell-reduced blood components for transfusions during early infancy.
    Rivers RP; Bedford Russell AR
    Transfusion; 1994 Feb; 34(2):185. PubMed ID: 8310496
    [No Abstract]   [Full Text] [Related]  

  • 4. [Risk of immunization to blood cells and diagnostic and therapeutic implications].
    Kiefel V
    Beitr Infusionsther; 1993; 31():44-51. PubMed ID: 7693263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocyte reduction of red blood cell transfusions does not decrease allosensitization rates in potential kidney transplant candidates.
    Karpinski M; Pochinco D; Dembinski I; Laidlaw W; Zacharias J; Nickerson P
    J Am Soc Nephrol; 2004 Mar; 15(3):818-24. PubMed ID: 14978185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization by platelet transfusion.
    Brand A
    Schweiz Med Wochenschr; 1991 Mar; 121(13):467-9. PubMed ID: 2031162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of reactions after exclusive transfusion of white cell-reduced cellular blood components.
    Dzieczkowski JS; Barrett BB; Nester D; Campbell M; Cook J; Sugrue M; Andersen JW; Anderson KC
    Transfusion; 1995 Jan; 35(1):20-5. PubMed ID: 7998063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of white cell-reduced red cells for transfusion through peripheral arterial lines.
    Derleth DP
    Transfusion; 1994 Jan; 34(1):86. PubMed ID: 8273140
    [No Abstract]   [Full Text] [Related]  

  • 9. [Alloimmunization and transfusion refractoriness to thrombocyte substitution].
    Söhngen D; Schneider W
    Klin Wochenschr; 1991 Jul; 69(10):419-25. PubMed ID: 1942953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some aspects of recent advances in the use of blood cell components.
    Schiffer CA
    Br J Haematol; 1978 Jul; 39(3):289-94. PubMed ID: 359030
    [No Abstract]   [Full Text] [Related]  

  • 11. Leukocyte reduction in blood component therapy.
    Lane TA; Anderson KC; Goodnough LT; Kurtz S; Moroff G; Pisciotto PT; Sayers M; Silberstein LE
    Ann Intern Med; 1992 Jul; 117(2):151-62. PubMed ID: 1605430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Special features of blood transfusions to hematologic patients].
    Oksanen K
    Duodecim; 1998; 114(12):1233-9. PubMed ID: 11524769
    [No Abstract]   [Full Text] [Related]  

  • 13. Granulocyte transfusions from G-CSF-stimulated donors for the treatment of severe infections in neutropenic pediatric patients with onco-hematological diseases.
    Cesaro S; Chinello P; De Silvestro G; Marson P; Picco G; Varotto S; Pittalis S; Zanesco L
    Support Care Cancer; 2003 Feb; 11(2):101-6. PubMed ID: 12560938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risks associated with blood transfusion in newborn infants.
    Blajchman MA; Sheridan D; Rawls WE
    Clin Perinatol; 1984 Jun; 11(2):403-15. PubMed ID: 6086206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolongation of cardiac allograft survival in rats by immunization with antibody-coated blood cells: changes in the T-cell compartment.
    Terness P; Thies JC; Koru T; Daniel V; Otto G; Süsal C; Opelz G
    Transplant Proc; 1992 Dec; 24(6):2562-4. PubMed ID: 1465867
    [No Abstract]   [Full Text] [Related]  

  • 16. [Washing and filtration of blood components: which indications are established?].
    Neppert J
    Beitr Infusionsther; 1993; 31():64-9. PubMed ID: 7693266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloimmunization after granulocyte transfusions.
    Stroncek DF; Leonard K; Eiber G; Malech HL; Gallin JI; Leitman SF
    Transfusion; 1996; 36(11-12):1009-15. PubMed ID: 8937413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Universal leukoreduction of cellular blood components in 2001? No.
    Goodnough LT
    Am J Clin Pathol; 2001 May; 115(5):674-7. PubMed ID: 11345830
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunological complications of platelet transfusion].
    Godeau B; Bierling P
    Ann Med Interne (Paris); 1992; 143(2):123-7. PubMed ID: 1530220
    [No Abstract]   [Full Text] [Related]  

  • 20. Leucocyte depletion of blood components.
    Bird A
    S Afr Med J; 2001 Oct; 91(10):822-3. PubMed ID: 11732450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.